Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3143)
All Articles published online
|
Jan 14, 2005 (publication date) through Jan 22, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang ZL, Liu ZS, Sun Q. Effects of thalidomide on angiogenesis and tumor growth and metastasis of human hepatocellular carcinoma in nude mice. World J Gastroenterol 2005; 11(2): 216-220 [PMID: 15633219 DOI: 10.3748/wjg.v11.i2.216] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i2/216.htm |
| Number | Citing Articles |
| 1 |
LIANG MIN, WEI LING, RONG HUA, HONG QI, SHENXU CHEN, HAIQIAO WANG, LUMEN TANG, WENJI SHANGGUAN. Anti-angiogenic therapy for normalization of tumor vasculature: A potential effect of Buyang Huanwu decoction on nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential. Molecular Medicine Reports 2016; 13(3): 2518 doi: 10.3892/mmr.2016.4854
|
| 2 |
Hollins P. Clark, W. Forrest Carson, Peter V. Kavanagh, Coty P. H. Ho, Perry Shen, Ronald J. Zagoria. Staging and Current Treatment of Hepatocellular Carcinoma. RadioGraphics 2005; 25(suppl_1): S3 doi: 10.1148/rg.25si055507
|
| 3 |
Elisabeth Heere-Ress, Johannes Boehm, Christiane Thallinger, Christoph Hoeller, Volker Wacheck, Peter Birner, Klaus Wolff, Hubert Pehamberger, Burkhard Jansen. Thalidomide Enhances the Anti-Tumor Activity of Standard Chemotherapy in a Human Melanoma Xenotransplatation Model. Journal of Investigative Dermatology 2005; 125(2): 201 doi: 10.1111/j.0022-202X.2005.23830.x
|
| 4 |
T Sohda, K Iwata, M Irie, Y Takeyama, H Nakane, D Morihara, Y Kitamura, M Yokoyama, S Shakado, H Watanabe, S Sakisaka. Characteristic Genotypes of Vascular Endothelial Growth Factor are Susceptible to Ascites in Patients with Cirrhosis. Journal of International Medical Research 2009; 37(3): 841 doi: 10.1177/147323000903700328
|
| 5 |
T. B. Gaspar, J. Henriques, L. Marconato, F. L. Queiroga. The use of low‐dose metronomic chemotherapy in dogs—insight into a modern cancer field. Veterinary and Comparative Oncology 2018; 16(1): 2 doi: 10.1111/vco.12309
|
| 6 |
ZHENGUO QIAO, JIGANG YUAN, JIAQING SHEN, CHAO WANG, ZHILONG HE, YIJIA HU, MUXING ZHANG, CHUNFANG XU. Effect of thalidomide in combination with gemcitabine on human pancreatic carcinoma SW-1990 cell lines in vitro and in vivo. Oncology Letters 2015; 9(5): 2353 doi: 10.3892/ol.2015.3064
|
| 7 |
Michael T. Scerba, David Tweedie, Nigel H. Greig. 2-(Piperidin-3-yl)phthalimides reduce classical markers of cellular inflammation in LPS-challenged RAW 264.7 cells and also demonstrate potentially relevant sigma and serotonin receptor affinity in membrane preparations. Bioorganic & Medicinal Chemistry Letters 2024; 110: 129885 doi: 10.1016/j.bmcl.2024.129885
|
| 8 |
Yuji Ishii, Taro Sakamoto, Rysuke Ito, Katsuhiko Yanaga. Anti-angiogenic Therapy on Hepatocellular Carcinoma Development and Progression. Journal of Surgical Research 2010; 158(1): 69 doi: 10.1016/j.jss.2008.09.015
|
| 9 |
Cristina Maria de Souza, Conrado de Oliveira Gamba, Cecília Bonolo de Campos, Miriam Teresa Paz Lopes, Mônica Alves Neves Diniz Ferreira, Silvia Passos Andrade, Geovanni Dantas Cassali. Carboplatin delays mammary cancer 4T1 growth in mice. Pathology - Research and Practice 2013; 209(1): 24 doi: 10.1016/j.prp.2012.10.003
|
| 10 |
Kanga Rani Selvaduray, Ammu K. Radhakrishnan, Methil Kannan Kutty, Kalanithi Nesaretnam. Palm tocotrienols decrease levels of pro-angiogenic markers in human umbilical vein endothelial cells (HUVEC) and murine mammary cancer cells. Genes & Nutrition 2012; 7(1): 53 doi: 10.1007/s12263-011-0223-0
|
| 11 |
Gonçalo N. Petrucci, Tomás Rodrigues Magalhães, Márcia Dias, Felisbina Luísa Queiroga. Metronomic chemotherapy: bridging theory to clinical application in canine and feline oncology. Frontiers in Veterinary Science 2024; 11 doi: 10.3389/fvets.2024.1397376
|
| 12 |
Michele Bertolotto, Gabriele Pozzato, Lory Saveria Crocè, Fabiana Nascimben, Cristiana Gasparini, Maria Assunta Cova, Claudio Tiribelli. Blood Flow Changes in Hepatocellular Carcinoma After the Administration of Thalidomide Assessed by Reperfusion Kinetics During Microbubble Infusion. Investigative Radiology 2006; 41(1): 15 doi: 10.1097/01.rli.0000188363.93670.45
|
| 13 |
Yanjie Lu, Qian Xu, Lei Chen, Yanzhen Zuo, Shaochen Liu, Yatao Hu, Xiaoru Li, Yuhong Li, Xiangyang Zhao. Expression of semaphorin 6D and its receptor plexin-A1 in gastric cancer and their association with tumor angiogenesis. Oncology Letters 2016; 12(5): 3967 doi: 10.3892/ol.2016.5208
|
| 14 |
Benjamin Chuah, Robert Lim, Michael Boyer, Ai-Bee Ong, Seng-Weng Wong, Hwai-Loong Kong, Michael Millward, Stephen Clarke, Boon-Cher Goh. Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinoma. Acta Oncologica 2007; 46(2): 234 doi: 10.1080/02841860600702076
|
| 15 |
Richard J. Epstein, Thomas W. Leung. Reversing Hepatocellular Carcinoma Progression by Using Networked Biological Therapies. Clinical Cancer Research 2007; 13(1): 11 doi: 10.1158/1078-0432.CCR-06-1619
|
| 16 |
Jan Škubník, Jiří Bejček, Vladimíra Svobodová Pavlíčková, Silvie Rimpelová. Repurposing Cardiac Glycosides: Drugs for Heart Failure Surmounting Viruses. Molecules 2021; 26(18): 5627 doi: 10.3390/molecules26185627
|
| 17 |
Zhong-Lin Zhang, Zhi-Su Liu, Quan Sun. Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(26): 4241-4245 doi: 10.3748/wjg.v12.i26.4241
|
| 18 |
Jun Ueyama, Masayuki Nadai, Ying Lan Zhao, Hiroaki Kanazawa, Kenji Takagi, Takaaki Kondo, Kenzo Takagi, Shinya Wakusawa, Fumie Abe, Hiroko Saito, Ken-ichi Miyamoto, Takaaki Hasegawa. Effect of Thalidomide on Endotoxin-Induced Decreases in Activity and Expression of Hepatic Cytochrome P450 3A2. Biological and Pharmaceutical Bulletin 2008; 31(8): 1596 doi: 10.1248/bpb.31.1596
|